Clinical Trials in Cagnes-sur-Mer, France
Locations / Cagnes-sur-Mer, France
Delta Trials records 34 clinical trials conducted in Cagnes-sur-Mer, France, making it a notable site of clinical research activity. These trials across 45 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Cagnes-sur-Mer has changed over time.
34
Total Trials
45
Conditions
1
Terminated since 2020
Browse by condition (45 total)
- Hypertension 5 trialsAll Hypertension trials
- Asthma 4 trialsAll Asthma trials
- All Non-squamous non-small cell lung cancer trials
- Ulcerative colitis 2 trialsAll Ulcerative colitis trials
- Healthy 2 trialsAll Healthy trials
- Smoking 1 trialAll Smoking trials
- All Non-metastatic patients with rectal cancer trials
- Psoriatic arthritis 1 trialAll Psoriatic arthritis trials
- Coronary patients 1 trialAll Coronary patients trials
- Crohn's disease 1 trialAll Crohn's disease trials
- All Non-metastatic patients with colon cancer trials
- Respiratory symptoms 1 trialAll Respiratory symptoms trials
- Dyslipidemia 1 trialAll Dyslipidemia trials
- COVID-19 1 trialAll COVID-19 trials
- Thromboembolism 1 trialAll Thromboembolism trials
- Lumbar total disk replacement 1 trialAll Lumbar total disk replacement trials
- Schizophrenia 1 trialAll Schizophrenia trials
- Idiopathic generalized epilepsy 1 trialAll Idiopathic generalized epilepsy trials
- Post menopausal osteoporosis 1 trialAll Post menopausal osteoporosis trials
- Ankylosing spondylitis 1 trialAll Ankylosing spondylitis trials